{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-103029","form_type":"8-K","ticker":"AMWL","cik":"0001393584","company_name":"American Well Corp","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.878726+00:00","generated_at":"2026-05-17T20:34:13.517328+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Amwell Q2 revenue $70.9M, net loss $19.5M; cuts FY2025 revenue guidance to $245M-$250M","bullets":["Revenue $70.9M (subscription $40.4M, AMG visits $22.8M); gross margin 56.1%.","Net loss $19.5M (vs $18.4M Q1); Adj. EBITDA loss improved to $4.7M from $12.2M Q1.","Added Florida Blue health plan; extended US Defense Health Agency contract.","FY2025 revenue guidance lowered to $245M-$250M from $250M-$260M; Adj. EBITDA narrowed to ($50M)-($45M).","Q3 2025 guidance: revenue $53M-$56M, Adj. EBITDA loss ($15M)-($13M)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-103029","json":"https://secwatch.observer/filing/0000950170-25-103029.json","markdown":"https://secwatch.observer/filing/0000950170-25-103029.md","text":"https://secwatch.observer/filing/0000950170-25-103029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393584/000095017025103029/0000950170-25-103029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393584/000095017025103029/amwl-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:34:13.517328+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}